At a glance
- Originator Malesci
- Class Antiasthmatics; Antibronchitics; Bronchodilators
- Mechanism of Action Phosphoric diester hydrolase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 12 Apr 2000 Discontinued-Preclinical for Asthma in Italy (Unknown route)
- 19 Aug 1997 No-Development-Reported for Asthma in Italy (Unknown route)
- 12 Jun 1995 New profile